Jiangsu Lianhuan Pharmaceutical Co., Ltd. (600513.SS)
CNY 8.96
(-4.78%)
CNY 8.96
(-4.78%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 259.87 Million CNY | -4.07% |
| 2022 | 255.04 Million CNY | 25.85% |
| 2021 | 206.71 Million CNY | 15.18% |
| 2020 | 180.88 Million CNY | 35.91% |
| 2019 | 131.08 Million CNY | 10.94% |
| 2018 | 114.93 Million CNY | -3.34% |
| 2017 | 118.82 Million CNY | 18.17% |
| 2016 | 104.46 Million CNY | 17.82% |
| 2015 | 81.03 Million CNY | 7.45% |
| 2014 | 75.58 Million CNY | 16.94% |
| 2013 | 62.02 Million CNY | 45.91% |
| 2012 | 49.48 Million CNY | 7.51% |
| 2011 | 42.04 Million CNY | 14.28% |
| 2010 | 36.46 Million CNY | 18.1% |
| 2009 | 31.05 Million CNY | 4.91% |
| 2008 | 28.48 Million CNY | 15.38% |
| 2007 | 24.21 Million CNY | 58.07% |
| 2006 | 17.82 Million CNY | 7.76% |
| 2005 | 16.53 Million CNY | -3.03% |
| 2004 | 17.05 Million CNY | -23.58% |
| 2003 | 22.31 Million CNY | -22.35% |
| 2002 | 28.73 Million CNY | 30.62% |
| 2001 | 22 Million CNY | 49.95% |
| 2000 | 14.67 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 48.2 Million CNY | -10.08% |
| 2024 Q1 | 53.6 Million CNY | -33.81% |
| 2024 Q3 | 41.69 Million CNY | -13.5% |
| 2023 Q2 | 45.71 Million CNY | -0.55% |
| 2023 Q4 | 65.02 Million CNY | 51.98% |
| 2023 Q3 | 42.78 Million CNY | -6.41% |
| 2023 Q1 | 45.96 Million CNY | -29.41% |
| 2023 FY | - CNY | -4.07% |
| 2022 Q3 | 55.98 Million CNY | 2.96% |
| 2022 Q4 | 65.12 Million CNY | 16.32% |
| 2022 Q2 | 54.37 Million CNY | 7.59% |
| 2022 FY | - CNY | 25.85% |
| 2022 Q1 | 50.53 Million CNY | 2.76% |
| 2021 FY | - CNY | 15.18% |
| 2021 Q1 | 42.16 Million CNY | 17.24% |
| 2021 Q2 | 45.57 Million CNY | 8.09% |
| 2021 Q3 | 47.05 Million CNY | 3.26% |
| 2021 Q4 | 49.18 Million CNY | 4.52% |
| 2020 Q4 | 35.96 Million CNY | -29.41% |
| 2020 FY | - CNY | 35.91% |
| 2020 Q1 | 34.24 Million CNY | 16.9% |
| 2020 Q3 | 50.94 Million CNY | 24.33% |
| 2020 Q2 | 40.97 Million CNY | 19.66% |
| 2019 Q1 | 23.23 Million CNY | -7.61% |
| 2019 FY | - CNY | 10.94% |
| 2019 Q2 | 34.68 Million CNY | 49.28% |
| 2019 Q3 | 28.08 Million CNY | -19.03% |
| 2019 Q4 | 29.29 Million CNY | 4.31% |
| 2018 FY | - CNY | -3.34% |
| 2018 Q4 | 25.14 Million CNY | 4.29% |
| 2018 Q2 | 29.89 Million CNY | 47.34% |
| 2018 Q1 | 20.29 Million CNY | -50.74% |
| 2018 Q3 | 24.11 Million CNY | -19.35% |
| 2017 Q4 | 41.19 Million CNY | 118.88% |
| 2017 Q2 | 29.44 Million CNY | 69.74% |
| 2017 Q1 | 17.34 Million CNY | -45.18% |
| 2017 Q3 | 18.81 Million CNY | -36.09% |
| 2017 FY | - CNY | 18.17% |
| 2016 FY | - CNY | 17.82% |
| 2016 Q3 | 20.43 Million CNY | -7.96% |
| 2016 Q2 | 22.2 Million CNY | 25.92% |
| 2016 Q1 | 17.63 Million CNY | -15.1% |
| 2016 Q4 | 31.64 Million CNY | 54.8% |
| 2015 FY | - CNY | 7.45% |
| 2015 Q4 | 20.77 Million CNY | 36.03% |
| 2015 Q3 | 15.26 Million CNY | -10.98% |
| 2015 Q2 | 17.15 Million CNY | -6.42% |
| 2015 Q1 | 18.32 Million CNY | 22.6% |
| 2014 Q2 | 20.44 Million CNY | 34.55% |
| 2014 Q1 | 15.19 Million CNY | -13.99% |
| 2014 FY | - CNY | 16.94% |
| 2014 Q4 | 14.95 Million CNY | -1.17% |
| 2014 Q3 | 15.12 Million CNY | -26.01% |
| 2013 Q2 | 19.58 Million CNY | 119.29% |
| 2013 FY | - CNY | 45.91% |
| 2013 Q4 | 17.66 Million CNY | 60.64% |
| 2013 Q1 | 8.93 Million CNY | -19.18% |
| 2013 Q3 | 10.99 Million CNY | -43.86% |
| 2012 Q3 | 10.13 Million CNY | 4.67% |
| 2012 Q2 | 9.68 Million CNY | 8.52% |
| 2012 FY | - CNY | 7.51% |
| 2012 Q1 | 8.92 Million CNY | 15.37% |
| 2012 Q4 | 11.05 Million CNY | 9.05% |
| 2011 Q4 | 7.73 Million CNY | -21.44% |
| 2011 Q2 | 9.32 Million CNY | 29.7% |
| 2011 Q1 | 7.19 Million CNY | 9.94% |
| 2011 FY | - CNY | 14.28% |
| 2011 Q3 | 9.84 Million CNY | 5.54% |
| 2010 Q3 | 8.05 Million CNY | -5.65% |
| 2010 FY | - CNY | 18.1% |
| 2010 Q4 | 6.54 Million CNY | -18.79% |
| 2010 Q1 | 6.62 Million CNY | 42.3% |
| 2010 Q2 | 8.53 Million CNY | 28.96% |
| 2009 Q1 | 5.05 Million CNY | -30.97% |
| 2009 FY | - CNY | 4.91% |
| 2009 Q2 | 8.34 Million CNY | 65.17% |
| 2009 Q3 | 7.05 Million CNY | -15.42% |
| 2009 Q4 | 4.65 Million CNY | -34.1% |
| 2008 Q3 | 4.7 Million CNY | -41.36% |
| 2008 Q4 | 7.32 Million CNY | 55.73% |
| 2008 Q2 | 8.01 Million CNY | 53.23% |
| 2008 Q1 | 5.23 Million CNY | -55.83% |
| 2008 FY | - CNY | 15.38% |
| 2007 Q1 | 2.77 Million CNY | -53.82% |
| 2007 Q2 | 4.87 Million CNY | 75.82% |
| 2007 Q3 | 3.58 Million CNY | -26.48% |
| 2007 Q4 | 11.84 Million CNY | 230.13% |
| 2007 FY | - CNY | 58.07% |
| 2006 Q1 | 4.89 Million CNY | -27.89% |
| 2006 Q4 | 6.01 Million CNY | 76.15% |
| 2006 Q3 | 3.41 Million CNY | -21.78% |
| 2006 FY | - CNY | 7.76% |
| 2006 Q2 | 4.36 Million CNY | -10.89% |
| 2005 Q2 | 5.99 Million CNY | 81.52% |
| 2005 FY | - CNY | -3.03% |
| 2005 Q1 | 3.3 Million CNY | 98.87% |
| 2005 Q3 | 2.72 Million CNY | -54.56% |
| 2005 Q4 | 6.78 Million CNY | 149.27% |
| 2004 Q3 | 6.28 Million CNY | 552.18% |
| 2004 Q4 | 1.66 Million CNY | -73.6% |
| 2004 Q1 | 12.44 Million CNY | 322.76% |
| 2004 Q2 | -1.39 Million CNY | -111.18% |
| 2004 FY | - CNY | -23.58% |
| 2003 Q3 | 4.55 Million CNY | -74.3% |
| 2003 Q4 | 2.94 Million CNY | -35.38% |
| 2003 Q1 | -4.31 Million CNY | -161.29% |
| 2003 Q2 | 17.72 Million CNY | 511.14% |
| 2003 FY | - CNY | -22.35% |
| 2002 Q4 | 7.03 Million CNY | 8.82% |
| 2002 Q1 | -4.18 Million CNY | 0.0% |
| 2002 FY | - CNY | 30.62% |
| 2002 Q3 | 6.46 Million CNY | -59.45% |
| 2002 Q2 | 15.94 Million CNY | 480.59% |
| 2001 FY | - CNY | 49.95% |
| 2000 FY | - CNY | 0.0% |